The Scientist
Date: June 23, 1997
Suzanne Ildstad
Professor and Director
Institute for Cellular Therapeutics
Allegheny University of the Health Sciences, Philadelphia.
Ildstad's major focus is to find a way to partially condition the recipient to accept a bone marrow graft to induce tolerance. Her research shows that by performing a bone marrow transplant, one can decrease the risk of rejection of kidneys, hearts, and pancreatic islets because the recipient's body has become tolerant of the donor antigens. Logistically, a bone marrow transplant is not always possible, and the drugs used to avoid rejection, nonspecific immunosuppressive agents, cause their own set of problems. Ildstad is hoping to discover a way to phase these out of treatment.
Ildstad says: "THE SCIENTIST is a very important periodical to keep scientists informed on the politics of academia and scientific discoveries. I benefit from the diverse topics covered by THE SCIENTIST by learning about ...
